Concepts and Models for Drug Permeability Studies
Concepts and Models for Drug Permeability Studies
Cell and Tissue based In Vitro Culture Models
Sarmento, Bruno; Leite Pereira, Catarina; Neves, Jose Das
Elsevier - Health Sciences Division
02/2024
706
Dura
Inglês
9780443155109
15 a 20 dias
Descrição não disponível.
1. Introduction
2. Importance and applications of cell- and tissue-based in vitro models for drug permeability screening in earlystages of drug development
Section I: Cell-based in vitro culture models for drug permeability studies: Immortalized and primary isolated cells
3.1. Cell-based in vitro models for buccal permeability studies
3.2. Cell-based in vitro models for gastric permeability studies
3.3. Cell-based in vitro models for intestinal permeability studies
3.4. Cell-based in vitro models for nasal permeability studies
3.5. Cell-based in vitro models for pulmonary permeability studies
3.6. Cell-based in vitro models for vaginal permeability studies
3.7. Cell-based in vitro models for transcorneal permeability studies
3.8. Cell-based in vitro models for dermal permeability studies
3.9. Tissue-based in vitro and ex vivo models for bloodebrain barrier permeability studies
3.10. Cell-based in vitro models for placental barrier permeability studies
Section II: Tissue-based in vitro and ex vivo models for drug permeability studies
4.1. Tissue-based in-vitro models for buccal permeability studies
4.2. Tissue-based in vitro and ex vivo models for intestinal permeability studies
4.3. Tissue-based in vitro and ex vivo models for nasal permeability studies
4.4. Tissue-based in vitro and ex vivo models for pulmonary permeability studies
4.5. Tissue-based models for vaginal permeability studies
4.6. Tissue-based models for ocular permeability studies
4.7. Tissue-based in vitro and ex vivo models for dermal permeability studies
4.8. Tissue-based in vitro and ex vivo models for bloodebrain barrier permeability studies Malgorzata Burek, Ellaine Salvador and Carola
4.9. Tissue-based ex vivo models for placental barrier permeability studies
Section III: Miniaturized models for drug permeability studies
5.1. Organ-on-chip models for intestinal permeability studies
5.2. Organ-on-chip models for pulmonary permeability studies
5.3. Organ-on-chip models for bloodebrain barrier permeability studies
5.4. Organ-on-chip models for other mucosal permeability studies
Section IV: Complex models for drug permeability studies
6.1. Multicompartmental dynamic models for permeability studies
6.2. Organoid-based models for permeability studies
7. Correlation between cell- and tissue-based in vitro models for drug permeability screening with in vivo situation: modeling and functional extrapolation
2. Importance and applications of cell- and tissue-based in vitro models for drug permeability screening in earlystages of drug development
Section I: Cell-based in vitro culture models for drug permeability studies: Immortalized and primary isolated cells
3.1. Cell-based in vitro models for buccal permeability studies
3.2. Cell-based in vitro models for gastric permeability studies
3.3. Cell-based in vitro models for intestinal permeability studies
3.4. Cell-based in vitro models for nasal permeability studies
3.5. Cell-based in vitro models for pulmonary permeability studies
3.6. Cell-based in vitro models for vaginal permeability studies
3.7. Cell-based in vitro models for transcorneal permeability studies
3.8. Cell-based in vitro models for dermal permeability studies
3.9. Tissue-based in vitro and ex vivo models for bloodebrain barrier permeability studies
3.10. Cell-based in vitro models for placental barrier permeability studies
Section II: Tissue-based in vitro and ex vivo models for drug permeability studies
4.1. Tissue-based in-vitro models for buccal permeability studies
4.2. Tissue-based in vitro and ex vivo models for intestinal permeability studies
4.3. Tissue-based in vitro and ex vivo models for nasal permeability studies
4.4. Tissue-based in vitro and ex vivo models for pulmonary permeability studies
4.5. Tissue-based models for vaginal permeability studies
4.6. Tissue-based models for ocular permeability studies
4.7. Tissue-based in vitro and ex vivo models for dermal permeability studies
4.8. Tissue-based in vitro and ex vivo models for bloodebrain barrier permeability studies Malgorzata Burek, Ellaine Salvador and Carola
4.9. Tissue-based ex vivo models for placental barrier permeability studies
Section III: Miniaturized models for drug permeability studies
5.1. Organ-on-chip models for intestinal permeability studies
5.2. Organ-on-chip models for pulmonary permeability studies
5.3. Organ-on-chip models for bloodebrain barrier permeability studies
5.4. Organ-on-chip models for other mucosal permeability studies
Section IV: Complex models for drug permeability studies
6.1. Multicompartmental dynamic models for permeability studies
6.2. Organoid-based models for permeability studies
7. Correlation between cell- and tissue-based in vitro models for drug permeability screening with in vivo situation: modeling and functional extrapolation
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Absorption; biopharmaceutics; biotechnology; bioengineering; drug development; drug transport
1. Introduction
2. Importance and applications of cell- and tissue-based in vitro models for drug permeability screening in earlystages of drug development
Section I: Cell-based in vitro culture models for drug permeability studies: Immortalized and primary isolated cells
3.1. Cell-based in vitro models for buccal permeability studies
3.2. Cell-based in vitro models for gastric permeability studies
3.3. Cell-based in vitro models for intestinal permeability studies
3.4. Cell-based in vitro models for nasal permeability studies
3.5. Cell-based in vitro models for pulmonary permeability studies
3.6. Cell-based in vitro models for vaginal permeability studies
3.7. Cell-based in vitro models for transcorneal permeability studies
3.8. Cell-based in vitro models for dermal permeability studies
3.9. Tissue-based in vitro and ex vivo models for bloodebrain barrier permeability studies
3.10. Cell-based in vitro models for placental barrier permeability studies
Section II: Tissue-based in vitro and ex vivo models for drug permeability studies
4.1. Tissue-based in-vitro models for buccal permeability studies
4.2. Tissue-based in vitro and ex vivo models for intestinal permeability studies
4.3. Tissue-based in vitro and ex vivo models for nasal permeability studies
4.4. Tissue-based in vitro and ex vivo models for pulmonary permeability studies
4.5. Tissue-based models for vaginal permeability studies
4.6. Tissue-based models for ocular permeability studies
4.7. Tissue-based in vitro and ex vivo models for dermal permeability studies
4.8. Tissue-based in vitro and ex vivo models for bloodebrain barrier permeability studies Malgorzata Burek, Ellaine Salvador and Carola
4.9. Tissue-based ex vivo models for placental barrier permeability studies
Section III: Miniaturized models for drug permeability studies
5.1. Organ-on-chip models for intestinal permeability studies
5.2. Organ-on-chip models for pulmonary permeability studies
5.3. Organ-on-chip models for bloodebrain barrier permeability studies
5.4. Organ-on-chip models for other mucosal permeability studies
Section IV: Complex models for drug permeability studies
6.1. Multicompartmental dynamic models for permeability studies
6.2. Organoid-based models for permeability studies
7. Correlation between cell- and tissue-based in vitro models for drug permeability screening with in vivo situation: modeling and functional extrapolation
2. Importance and applications of cell- and tissue-based in vitro models for drug permeability screening in earlystages of drug development
Section I: Cell-based in vitro culture models for drug permeability studies: Immortalized and primary isolated cells
3.1. Cell-based in vitro models for buccal permeability studies
3.2. Cell-based in vitro models for gastric permeability studies
3.3. Cell-based in vitro models for intestinal permeability studies
3.4. Cell-based in vitro models for nasal permeability studies
3.5. Cell-based in vitro models for pulmonary permeability studies
3.6. Cell-based in vitro models for vaginal permeability studies
3.7. Cell-based in vitro models for transcorneal permeability studies
3.8. Cell-based in vitro models for dermal permeability studies
3.9. Tissue-based in vitro and ex vivo models for bloodebrain barrier permeability studies
3.10. Cell-based in vitro models for placental barrier permeability studies
Section II: Tissue-based in vitro and ex vivo models for drug permeability studies
4.1. Tissue-based in-vitro models for buccal permeability studies
4.2. Tissue-based in vitro and ex vivo models for intestinal permeability studies
4.3. Tissue-based in vitro and ex vivo models for nasal permeability studies
4.4. Tissue-based in vitro and ex vivo models for pulmonary permeability studies
4.5. Tissue-based models for vaginal permeability studies
4.6. Tissue-based models for ocular permeability studies
4.7. Tissue-based in vitro and ex vivo models for dermal permeability studies
4.8. Tissue-based in vitro and ex vivo models for bloodebrain barrier permeability studies Malgorzata Burek, Ellaine Salvador and Carola
4.9. Tissue-based ex vivo models for placental barrier permeability studies
Section III: Miniaturized models for drug permeability studies
5.1. Organ-on-chip models for intestinal permeability studies
5.2. Organ-on-chip models for pulmonary permeability studies
5.3. Organ-on-chip models for bloodebrain barrier permeability studies
5.4. Organ-on-chip models for other mucosal permeability studies
Section IV: Complex models for drug permeability studies
6.1. Multicompartmental dynamic models for permeability studies
6.2. Organoid-based models for permeability studies
7. Correlation between cell- and tissue-based in vitro models for drug permeability screening with in vivo situation: modeling and functional extrapolation
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.